Paper21154343
Methylxanthine treatment for apnoea in preterm infants.
Henderson-Smart DJ and 1 other. Cochrane Database Syst Rev, 2010. Cited by 154 papers, by iCite.
Cite this record
ConductScience Library. Methylxanthine treatment for apnoea in preterm infants. Papers, record 21154343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21154343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apnea | Major topic |
| Central Nervous System Stimulants | Major topic |
| Infant, Premature, Diseases | Major topic |
| Vasodilator Agents | Major topic |
| Xanthines | Major topic |
| Caffeine | |
| Humans | |
| Infant, Newborn | |
| Infant, Premature | |
| Intermittent Positive-Pressure Ventilation | |
| Randomized Controlled Trials as Topic | |
| Theophylline |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Update of | 11686952 | Methylxanthine treatment for apnea in preterm infants. | https://conductscience.org/library/papers/11686952 | PubMed |
| Comment in | 21447523 | In preterm infants with recurrent apnoea, methylxanthine reduces the number of episodes and the use of mechanical ventilation in the short term; caffeine is also associated with improved longer term outcomes. | https://conductscience.org/library/papers/21447523 | PubMed |
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19057373 | Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. | Ther Drug Monit | 2008 | https://conductscience.org/library/papers/19057373 | PubMed |
| 2 | 7310594 | The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. | J Pediatr | 1981 | https://conductscience.org/library/papers/7310594 | PubMed |
| 3 | 11220405 | Caffeine citrate: a review of its use in apnoea of prematurity. | Paediatr Drugs | 2001 | https://conductscience.org/library/papers/11220405 | PubMed |
| 4 | 15494987 | Doxapram treatment for apnea in preterm infants. | Cochrane Database Syst Rev | 2004 | https://conductscience.org/library/papers/15494987 | PubMed |
| 5 | 10796361 | Prophylactic methylxanthine for preventing of apnea in preterm infants. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/10796361 | PubMed |
| 6 | 10518091 | Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway? | J Pediatr | 1999 | https://conductscience.org/library/papers/10518091 | PubMed |
| 7 | 12032788 | A randomized, controlled, double-blind trial comparing two loading doses of aminophylline. | J Perinatol | 2002 | https://conductscience.org/library/papers/12032788 | PubMed |
| 8 | 17989382 | Long-term effects of caffeine therapy for apnea of prematurity. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17989382 | PubMed |
| 9 | 7347217 | Theophylline in treatment of apnoea of prematurity. | Aust Paediatr J | 1981 | https://conductscience.org/library/papers/7347217 | PubMed |
| 10 | 11686952 | Methylxanthine treatment for apnea in preterm infants. | Cochrane Database Syst Rev | 2001 | https://conductscience.org/library/papers/11686952 | PubMed |
| 11 | 3890520 | Limitations of theophylline in the treatment of apnea of prematurity. | Am J Dis Child | 1985 | https://conductscience.org/library/papers/3890520 | PubMed |
| 12 | 16707748 | Caffeine therapy for apnea of prematurity. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16707748 | PubMed |
| 13 | 9602179 | Neonatal apnea, bradycardia, or desaturation: does it matter? | J Pediatr | 1998 | https://conductscience.org/library/papers/9602179 | PubMed |
| 14 | 10723691 | Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight. | J Paediatr Child Health | 2000 | https://conductscience.org/library/papers/10723691 | PubMed |
| 15 | 12671135 | Apnea, sudden infant death syndrome, and home monitoring. | Pediatrics | 2003 | https://conductscience.org/library/papers/12671135 | PubMed |
| 16 | 19926098 | Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups. | J Pediatr | 2010 | https://conductscience.org/library/papers/19926098 | PubMed |
| 17 | 11034672 | Doxapram versus methylxanthine for apnea in preterm infants. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/11034672 | PubMed |
| 18 | 10796303 | Prophylactic methylxanthine for extubation in preterm infants. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/10796303 | PubMed |
| 19 | 2181103 | A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. | J Pediatr | 1990 | https://conductscience.org/library/papers/2181103 | PubMed |
| 20 | 10853619 | Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. | Pharmacotherapy | 2000 | https://conductscience.org/library/papers/10853619 | PubMed |
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940670 | Doxapram in Preterm Infants: From Respiratory Stimulation to Individualized Therapy-A Narrative Review. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42940670 | PubMed |
| 42871650 | Neonatal apnea research: a bibliometric analysis of trends, clusters, and paradigm shifts. | Transl Pediatr | 2026 | https://conductscience.org/library/papers/42871650 | PubMed |
| 42718862 | Association of caffeine citrate plus vitamin A/D drops with bronchopulmonary dysplasia and respiratory outcomes in preterm infants born at <32 weeks' gestation: a 72-h landmark retrospective cohort study. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42718862 | PubMed |
| 42187335 | Early Versus Conventional Discontinuation of Caffeine Therapy for Apnea of Prematurity: A Randomized Controlled Trial-The DECaf Trial. | Pediatr Pulmonol | 2026 | https://conductscience.org/library/papers/42187335 | PubMed |
| 41653310 | Caffeine and other methylxanthines' impact on bronchiolitis-related apnea in under 12-months-old children-a systematic review with meta-analyses. | Eur J Pediatr | 2026 | https://conductscience.org/library/papers/41653310 | PubMed |
| 41639373 | Caffeine addiction: optimising neonatal caffeine use. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41639373 | PubMed |
| 41597061 | Methylxanthine Treatment in Neonates Admitted to the Special Care Unit: An Observational Study in Low-Resource Settings. | Children (Basel) | 2025 | https://conductscience.org/library/papers/41597061 | PubMed |
| 41488904 | Pharmacological treatment for apnoea of prematurity-the need for an individualised approach. | Front Pediatr | 2025 | https://conductscience.org/library/papers/41488904 | PubMed |
| 40995968 | Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease. | Pediatr Pulmonol | 2025 | https://conductscience.org/library/papers/40995968 | PubMed |
| 40390868 | Caffeine Treatment for Prostaglandin E1-Induced Apnea Prevention in Congenital Heart Disease Neonates: A Randomized Clinical Trial. | Crit Care Res Pract | 2025 | https://conductscience.org/library/papers/40390868 | PubMed |
| 40072976 | Caffeine-clarithromycin coadministration and hyperlactatemia in a young infant: a case report. | Crit Care Sci | 2025 | https://conductscience.org/library/papers/40072976 | PubMed |
| 40038163 | Evaluation of the safety of doxapram in premature neonates born before 28 weeks of gestation. | Eur J Pediatr | 2025 | https://conductscience.org/library/papers/40038163 | PubMed |
| 39334735 | Caffeine: The Story beyond Oxygen-Induced Lung and Brain Injury in Neonatal Animal Models-A Narrative Review. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39334735 | PubMed |
| 39331390 | Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions: A Meta-Analysis. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39331390 | PubMed |
| 39301040 | A nomogram for predicting neonatal apnea: a retrospective analysis based on the MIMIC database. | Front Pediatr | 2024 | https://conductscience.org/library/papers/39301040 | PubMed |
| 38898410 | Predictors for poor daily weight gain in preterm neonates exposed to different dose regimens of caffeine in ICU- a retrospective cohort study. | BMC Pediatr | 2024 | https://conductscience.org/library/papers/38898410 | PubMed |
| 38798766 | A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit. | J Pharm Policy Pract | 2024 | https://conductscience.org/library/papers/38798766 | PubMed |
| 38666733 | Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study. | Inquiry | 2024 | https://conductscience.org/library/papers/38666733 | PubMed |
| 38617389 | Dose-Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates-A Retrospective Cohort Study. | Dose Response | 2024 | https://conductscience.org/library/papers/38617389 | PubMed |
| 38125677 | The effect of acute respiratory events and respiratory stimulants on EEG-recorded brain activity in neonates: A systematic review. | Clin Neurophysiol Pract | 2023 | https://conductscience.org/library/papers/38125677 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21154343
GET https://conductscience.org/api/papers/v1/21154343/cited_by?page=2